Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICA9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006364 | rRNA processing | 8 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016072 | rRNA metabolic process | 7 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 278 | 282 | PF00656 | 0.426 |
CLV_C14_Caspase3-7 | 303 | 307 | PF00656 | 0.677 |
CLV_C14_Caspase3-7 | 600 | 604 | PF00656 | 0.581 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.360 |
CLV_NRD_NRD_1 | 320 | 322 | PF00675 | 0.438 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.458 |
CLV_NRD_NRD_1 | 451 | 453 | PF00675 | 0.449 |
CLV_NRD_NRD_1 | 503 | 505 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.374 |
CLV_NRD_NRD_1 | 541 | 543 | PF00675 | 0.540 |
CLV_PCSK_FUR_1 | 317 | 321 | PF00082 | 0.611 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 323 | 325 | PF00082 | 0.505 |
CLV_PCSK_KEX2_1 | 451 | 453 | PF00082 | 0.449 |
CLV_PCSK_KEX2_1 | 503 | 505 | PF00082 | 0.479 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.370 |
CLV_PCSK_KEX2_1 | 541 | 543 | PF00082 | 0.536 |
CLV_PCSK_KEX2_1 | 576 | 578 | PF00082 | 0.486 |
CLV_PCSK_KEX2_1 | 596 | 598 | PF00082 | 0.530 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.464 |
CLV_PCSK_PC1ET2_1 | 319 | 321 | PF00082 | 0.535 |
CLV_PCSK_PC1ET2_1 | 576 | 578 | PF00082 | 0.505 |
CLV_PCSK_PC1ET2_1 | 596 | 598 | PF00082 | 0.569 |
CLV_PCSK_PC1ET2_1 | 97 | 99 | PF00082 | 0.464 |
CLV_PCSK_PC7_1 | 320 | 326 | PF00082 | 0.590 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 453 | 457 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 460 | 464 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 509 | 513 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 519 | 523 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 625 | 629 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.399 |
DEG_APCC_DBOX_1 | 481 | 489 | PF00400 | 0.622 |
DEG_SCF_TRCP1_1 | 372 | 378 | PF00400 | 0.490 |
DOC_ANK_TNKS_1 | 598 | 605 | PF00023 | 0.595 |
DOC_MAPK_gen_1 | 522 | 533 | PF00069 | 0.469 |
DOC_MAPK_MEF2A_6 | 104 | 112 | PF00069 | 0.440 |
DOC_PP1_RVXF_1 | 263 | 269 | PF00149 | 0.397 |
DOC_PP4_FxxP_1 | 234 | 237 | PF00568 | 0.421 |
DOC_USP7_MATH_1 | 298 | 302 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 609 | 613 | PF00917 | 0.627 |
DOC_USP7_UBL2_3 | 315 | 319 | PF12436 | 0.608 |
DOC_USP7_UBL2_3 | 449 | 453 | PF12436 | 0.479 |
DOC_USP7_UBL2_3 | 456 | 460 | PF12436 | 0.476 |
DOC_USP7_UBL2_3 | 501 | 505 | PF12436 | 0.492 |
DOC_USP7_UBL2_3 | 625 | 629 | PF12436 | 0.503 |
DOC_WW_Pin1_4 | 233 | 238 | PF00397 | 0.498 |
LIG_14-3-3_CanoR_1 | 265 | 269 | PF00244 | 0.433 |
LIG_14-3-3_CanoR_1 | 275 | 280 | PF00244 | 0.436 |
LIG_14-3-3_CanoR_1 | 381 | 387 | PF00244 | 0.552 |
LIG_14-3-3_CanoR_1 | 597 | 606 | PF00244 | 0.653 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.559 |
LIG_CaM_IQ_9 | 422 | 438 | PF13499 | 0.592 |
LIG_CaM_IQ_9 | 534 | 550 | PF13499 | 0.588 |
LIG_CSL_BTD_1 | 41 | 44 | PF09270 | 0.617 |
LIG_FHA_1 | 493 | 499 | PF00498 | 0.465 |
LIG_FHA_1 | 532 | 538 | PF00498 | 0.630 |
LIG_FHA_1 | 557 | 563 | PF00498 | 0.406 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.628 |
LIG_FHA_2 | 284 | 290 | PF00498 | 0.470 |
LIG_FHA_2 | 538 | 544 | PF00498 | 0.547 |
LIG_LIR_Apic_2 | 231 | 237 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 62 | 71 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 62 | 66 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 70 | 75 | PF02991 | 0.369 |
LIG_Pex14_2 | 264 | 268 | PF04695 | 0.378 |
LIG_REV1ctd_RIR_1 | 617 | 628 | PF16727 | 0.606 |
LIG_SH2_CRK | 326 | 330 | PF00017 | 0.470 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.383 |
LIG_SH2_NCK_1 | 193 | 197 | PF00017 | 0.317 |
LIG_SH2_NCK_1 | 606 | 610 | PF00017 | 0.495 |
LIG_SH2_STAP1 | 326 | 330 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 72 | 76 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 227 | 230 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 606 | 609 | PF00017 | 0.570 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.748 |
LIG_SUMO_SIM_par_1 | 84 | 89 | PF11976 | 0.472 |
LIG_TRAF2_1 | 28 | 31 | PF00917 | 0.673 |
LIG_TRAF2_1 | 286 | 289 | PF00917 | 0.656 |
LIG_WRC_WIRS_1 | 195 | 200 | PF05994 | 0.323 |
MOD_CDK_SPxxK_3 | 233 | 240 | PF00069 | 0.493 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.664 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.355 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.610 |
MOD_CK1_1 | 257 | 263 | PF00069 | 0.483 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.608 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.652 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.586 |
MOD_CK2_1 | 283 | 289 | PF00069 | 0.605 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.487 |
MOD_CK2_1 | 380 | 386 | PF00069 | 0.591 |
MOD_CK2_1 | 496 | 502 | PF00069 | 0.508 |
MOD_CK2_1 | 537 | 543 | PF00069 | 0.551 |
MOD_Cter_Amidation | 594 | 597 | PF01082 | 0.551 |
MOD_Cter_Amidation | 95 | 98 | PF01082 | 0.378 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.768 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.360 |
MOD_GlcNHglycan | 217 | 221 | PF01048 | 0.373 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.446 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.717 |
MOD_GlcNHglycan | 371 | 375 | PF01048 | 0.492 |
MOD_GlcNHglycan | 498 | 501 | PF01048 | 0.501 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.700 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.702 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.632 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.424 |
MOD_GSK3_1 | 417 | 424 | PF00069 | 0.663 |
MOD_GSK3_1 | 488 | 495 | PF00069 | 0.464 |
MOD_GSK3_1 | 556 | 563 | PF00069 | 0.501 |
MOD_GSK3_1 | 609 | 616 | PF00069 | 0.596 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.497 |
MOD_N-GLC_1 | 9 | 14 | PF02516 | 0.527 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.377 |
MOD_NEK2_1 | 279 | 284 | PF00069 | 0.517 |
MOD_NEK2_1 | 455 | 460 | PF00069 | 0.601 |
MOD_NEK2_1 | 531 | 536 | PF00069 | 0.554 |
MOD_NEK2_1 | 569 | 574 | PF00069 | 0.596 |
MOD_NEK2_1 | 585 | 590 | PF00069 | 0.305 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.523 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.385 |
MOD_PIKK_1 | 531 | 537 | PF00454 | 0.684 |
MOD_PIKK_1 | 569 | 575 | PF00454 | 0.547 |
MOD_PKA_2 | 264 | 270 | PF00069 | 0.394 |
MOD_PKA_2 | 380 | 386 | PF00069 | 0.539 |
MOD_PKA_2 | 496 | 502 | PF00069 | 0.665 |
MOD_Plk_1 | 375 | 381 | PF00069 | 0.573 |
MOD_Plk_1 | 410 | 416 | PF00069 | 0.556 |
MOD_Plk_1 | 613 | 619 | PF00069 | 0.577 |
MOD_Plk_1 | 86 | 92 | PF00069 | 0.483 |
MOD_Plk_2-3 | 143 | 149 | PF00069 | 0.684 |
MOD_Plk_4 | 402 | 408 | PF00069 | 0.650 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.486 |
MOD_ProDKin_1 | 233 | 239 | PF00069 | 0.494 |
MOD_SUMO_rev_2 | 116 | 125 | PF00179 | 0.573 |
MOD_SUMO_rev_2 | 307 | 316 | PF00179 | 0.639 |
MOD_SUMO_rev_2 | 415 | 423 | PF00179 | 0.509 |
MOD_SUMO_rev_2 | 600 | 607 | PF00179 | 0.635 |
TRG_DiLeu_BaEn_4 | 30 | 36 | PF01217 | 0.613 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 326 | 329 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.374 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.455 |
TRG_ER_diArg_1 | 320 | 323 | PF00400 | 0.456 |
TRG_ER_diArg_1 | 324 | 326 | PF00400 | 0.478 |
TRG_ER_diArg_1 | 450 | 452 | PF00400 | 0.454 |
TRG_ER_diArg_1 | 53 | 55 | PF00400 | 0.390 |
TRG_ER_diLys_1 | 624 | 629 | PF00400 | 0.511 |
TRG_NES_CRM1_1 | 377 | 391 | PF08389 | 0.711 |
TRG_NES_CRM1_1 | 70 | 84 | PF08389 | 0.347 |
TRG_NLS_Bipartite_1 | 504 | 526 | PF00514 | 0.488 |
TRG_NLS_MonoCore_2 | 622 | 627 | PF00514 | 0.458 |
TRG_NLS_MonoExtC_3 | 455 | 460 | PF00514 | 0.472 |
TRG_NLS_MonoExtC_3 | 521 | 526 | PF00514 | 0.509 |
TRG_NLS_MonoExtC_3 | 595 | 601 | PF00514 | 0.586 |
TRG_NLS_MonoExtN_4 | 453 | 460 | PF00514 | 0.490 |
TRG_NLS_MonoExtN_4 | 519 | 526 | PF00514 | 0.474 |
TRG_NLS_MonoExtN_4 | 593 | 600 | PF00514 | 0.564 |
TRG_NLS_MonoExtN_4 | 623 | 628 | PF00514 | 0.464 |
TRG_Pf-PMV_PEXEL_1 | 15 | 19 | PF00026 | 0.614 |
TRG_Pf-PMV_PEXEL_1 | 98 | 103 | PF00026 | 0.427 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2Z4 | Leptomonas seymouri | 71% | 86% |
A0A0S4IQI8 | Bodo saltans | 48% | 85% |
A0A1X0NN45 | Trypanosomatidae | 54% | 85% |
A0A3S5IRC1 | Trypanosoma rangeli | 53% | 92% |
A0A3S7XCB2 | Leishmania donovani | 98% | 100% |
A4HQH3 | Leishmania braziliensis | 81% | 100% |
D0A3M2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 88% |
E9AU86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q0A5 | Leishmania major | 92% | 100% |
V5AXL9 | Trypanosoma cruzi | 54% | 92% |